Advantageous Predictors of Acute Coronary Syndromes Evaluation
Initiatives
-
To test if the use of meticulous patient history, digital and analogue ECG parameter and novel biomarkers (including novel, sensitive and high-sensitive cardiac troponin I and T, Copeptin, myeloperoxydase, Endothelin) can provide a faster detection or exclusion of acute myocardial infarction in patients presenting with acute chest pain to the emergency department.
- Start Year
- 2006
- Funding
- University Hospital, Basel, Switzerland
Visit APACE
Investigators | Contacts |
---|---|
|
Design
- Study design
- Patients' cohort
- Follow Up
- . All patients will be contacted by telephone at 6, 12, 24 and 60 months to determine functional status, major adverse cardiac events (death, myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention), and the results of cardiac examination (stress test, coronary angiography) if performed.
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 8,000
- Number of participants with biosamples
- Supplementary Information
- Over 18 years old
Access
Availability of data and biosamples
Data | |
Biosamples | |
Other |
Availability of access information
On the study website : http://www.dyspnea.ch/apace.htm